Perelman School of Medicine

Radiation-induced breast cancer risk from digital mammography is low for the majority of women, but risk is higher in women with large breasts, who received 2.3 times more radiation and required more views per examination to image as much of the breast as possible compared to those with small or average-sized breasts.

Health warning labels similar to those found on tobacco products may have a powerful effect on whether parents purchase sugar-sweetened beverages (SSB) for their children, according to a new study led by the Perelman School of Medicine at the University of Pennsylvania.

WHO: Michael Platt Penn Integrates Knowledge Professor James S. Riepe University Professor of Neuroscience Perelman School of Medicine

When Shiho Nagai began attending the informal, not-for-credit slanguage sessions at the University of Pennsylvania’s Christian Association, she had in mind improving her English skills.

A nonsteroidal anti-inflammatory drug (NSAID) changed the composition and diversity of gut microbes, which in turn shaped how the drug is broken down and ultimately, cut its effectiveness, according to an animal study from the Perelman School of Medicine at the University of Pennsylvania.

In Florida carpenter ant colonies, distinct worker castes called minors and majors exhibit pronounced differences in social behavior throughout their lives. In a new study published today in Science, a multi-institution team anchored at University of Pennsylvania found that these caste-specific behaviors are not set in stone.

Murray Grossman, MD, EdD, a professor of Neurology in the Perelman School of Medicine at the University of Pennsylvania and director of Penn’s Frontotemporal Degeneration (FTD) Center, recently received the Legal Clinic for

Penn Medicine’s Gary Lichtenstein, MD, a professor of Medicine and Gary Wu, MD, the Ferdinand G.

Palbociclib, a new oral drug whose efficacy in combating breast cancer has been demonstrated alone and in combination with endocrine therapy, also has potential to combat other types of cancer, according to a literature review and additional original research conducted by experts at the

Recurrence of HER2-positive breast cancer after treatment may be due to a specific and possibly cancer-induced weakness in the patient’s immune system – a weakness that in principle could be corrected with a HER2-targeted vaccine – according to a new study from the Perelman School of Medicine at the University of Pennsylvania. Results of the study show that T cells from patien